Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
CNY 4.19
(-0.48%)
CNY 4.19
(-0.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.46 Billion | 6.35 Billion | 6.47 Billion | 5.84 Billion | 6.65 Billion | 6.58 Billion |
| Cost of Revenue | 5.34 Billion | 5.13 Billion | 5.11 Billion | 4.59 Billion | 5.19 Billion | 5.14 Billion |
| Gross Profit | 1.11 Billion | 1.21 Billion | 1.35 Billion | 1.25 Billion | 1.46 Billion | 1.43 Billion |
| Operating Expenses | 843.54 Million | 836.44 Million | 787.14 Million | 802.12 Million | 943.72 Million | 929.1 Million |
| Selling, General and Administrative Expenses | 394.16 Million | 543.28 Million | 487.38 Million | 523.25 Million | 581.72 Million | 580.94 Million |
| Research and Development Expenses | 4.67 Million | 1.2 Million | 1.93 Million | 10.56 Million | 36.57 Million | 36.69 Million |
| Other Expenses | 444.7 Million | 291.95 Million | 297.82 Million | 268.3 Million | 325.42 Million | -16.04 Million |
| Cost and Expenses | 6.07 Billion | 5.96 Billion | 5.9 Billion | 5.39 Billion | 6.13 Billion | 6.07 Billion |
| Operating Income | 385.03 Million | 427.81 Million | 451.51 Million | 429.9 Million | 526.56 Million | -1.19 Billion |
| Interest Expense | 40.48 Million | 51.78 Million | 100.19 Million | 99.61 Million | 164.76 Million | 149.84 Million |
| Income Tax Expense | 42.24 Million | 44.97 Million | 47.16 Million | 46.88 Million | 67.75 Million | 71.77 Million |
| Earnings before Tax | 396.02 Million | 313.39 Million | 421.12 Million | 267.45 Million | 331.47 Million | -1.21 Billion |
| Net Income | 287.23 Million | 224.37 Million | 373.95 Million | 173.52 Million | 236.3 Million | -1.29 Billion |
| Earnings Per Share Basic | 0.15 | 0.12 | 0.21 | 0.11 | 0.15 | -0.80 |
| Earnings Per Share Diluted | 0.15 | 0.12 | 0.21 | 0.11 | 0.15 | -0.80 |
| Weighted Average Shares Outstanding | 1.91 Billion | 1.94 Billion | 1.81 Billion | 1.58 Billion | 1.59 Billion | 1.62 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.91 Billion | 1.94 Billion | 1.81 Billion | 1.58 Billion | 1.59 Billion | 1.62 Billion |
| Gross Margin | 0.17 | 0.19 | 0.21 | 0.21 | 0.22 | 0.22 |
| EBIT Margin | 0.10 | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 |
| Profit Margin | 0.04 | 0.04 | 0.06 | 0.03 | 0.04 | -0.20 |
| EBITDA | 654.01 Million | 608.72 Million | 768.64 Million | 632.49 Million | 734.62 Million | -825.85 Million |
| Earnings Before Tax Margin | 0.06 | 0.07 | 0.07 | 0.07 | 0.08 | -0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.51 Billion | 1.46 Billion | 1.57 Billion | 6.43 Billion | 1.63 Billion | 1.56 Billion |
| Cost of Revenue | 1.22 Billion | 1.19 Billion | 1.3 Billion | 5.34 Billion | 1.39 Billion | 1.23 Billion |
| Gross Profit | 288.63 Million | 270.15 Million | 268.31 Million | 1.09 Billion | 235.62 Million | 327.74 Million |
| Operating Expenses | 187.32 Million | 160.51 Million | 183.8 Million | 694.3 Million | 197.79 Million | 189.55 Million |
| Selling, General and Administrative Expenses | 185.65 Million | 10.91 Million | 182.93 Million | - | 187.65 Million | 335.6 Million |
| Research and Development Expenses | 1.66 Million | 1.28 Million | 865.88 Thousand | - | 2.61 Million | 381.05 Thousand |
| Other Expenses | - | -662.68 Thousand | -1 Million | -7.32 Million | -7.52 Million | -4.2 Million |
| Cost and Expenses | 1.41 Billion | 1.35 Billion | 1.49 Billion | 6.03 Billion | 1.59 Billion | 1.42 Billion |
| Operating Income | 101.3 Million | 87.16 Million | 84.51 Million | 398.18 Million | 37.83 Million | 131.08 Million |
| Interest Expense | 5.97 Million | 5.93 Million | 6.66 Million | 39.69 Million | 7.33 Million | 10.79 Million |
| Income Tax Expense | 16.88 Million | 6.75 Million | 7.89 Million | 42.24 Million | 9.99 Million | 15.03 Million |
| Earnings before Tax | 98.18 Million | 86.49 Million | 79.59 Million | 396.02 Million | 60.32 Million | 126.87 Million |
| Net Income | 61.71 Million | 56.05 Million | 58.82 Million | 287.23 Million | 40.65 Million | 90.55 Million |
| Earnings Per Share Basic | 0.03 | 0.03 | 0.03 | - | 0.02 | 0.05 |
| Earnings Per Share Diluted | 0.03 | 0.03 | 0.03 | - | 0.02 | 0.05 |
| Weighted Average Shares Outstanding | 1.89 Billion | 1.89 Billion | 1.9 Billion | 1.91 Billion | 1.91 Billion | 1.93 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.89 Billion | 1.89 Billion | 1.9 Billion | 1.91 Billion | 1.91 Billion | 1.93 Billion |
| Gross Margin | 0.19 | 0.18 | 0.17 | 0.17 | 0.14 | 0.21 |
| EBIT Margin | 0.07 | 0.08 | 0.06 | - | 0.06 | 0.09 |
| Profit Margin | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.06 |
| EBITDA | 104.16 Million | 110.79 Million | 89.6 Million | - | 101.67 Million | 137.68 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.05 | 0.06 | 0.02 | 0.08 |
605599
IDGAF
600171
300683
QIIWI
STAR-B